On the recordOctober 2, 2017
I know it may be a bit premature, but are you able to share any statistics on the impact of these two modernizations to the expanded access program?
Source
congress.govEditor's note · Context
Greg Walden inquires about the impact of FDA reforms on expanded access for patients.
Share
More from Greg Walden
Dec 9, 2020
It is a great privilege now to recognize the gentleman from Kentucky (Mr. Guthrie), who is the top Republican on the Oversight and Investigations Subcommittee and has really done incredible work as we put together our package on Operation…
Dec 9, 2020
Before I yield to the author of the bill, the gentleman from Texas, I can tell you, Texas has few stronger advocates, if any, than Mr. Olson. And Texas 22, his congressional district, has had an incredibly effective voice in the United…
Sep 29, 2020
I thank the majority leader for his comments in support and authorship of this legislation. Our son battled childhood asthma. It is a really scary thing as a parent to watch a child deal with an asthma attack. Madam Speaker, I yield such…
Oct 1, 2020
I thank my colleagues for bringing this legislation forward, and especially Chairman Grijalva and Ranking Member Bishop. I also thank Oregon senators, Merkley and Wyden, for their efforts on this, too. Irrigators in the Klamath Basin…
Other voices in this conversation
